Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Endometrial Clear Cell Adenocarcinoma

Known as: clearcell carcinoma of the uterus, Clear Cell Carcinoma of Endometrium, carcinoma of the uterus, clearcell 
A high-grade endometrial adenocarcinoma characterized by the presence of large neoplastic cells that display at least focal cytoplasmic clearing. The… Expand
National Institutes of Health

Related topics

Related topics

19 relations
Adenocarcinoma Cell with Intracytoplasmic MucinAdenocarcinoma, Clear CellBody of uterusEndometrium
Expand

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2017
Review
2017
The genetic landscape of endometrial clear cell carcinomas.
Clear cell carcinoma of the endometrium is a rare type of endometrial cancer that is generally associated with an aggressive… Expand
  • table 1
  • figure 1
  • figure 2
  • table 2
  • figure 3
Is this relevant?
2014
2014
Immunohistochemical characterization of prototypical endometrial clear cell carcinoma--diagnostic utility of HNF-1β and oestrogen receptor.
AIMS The great majority of ovarian clear cell carcinomas have a hepatocyte nuclear factor 1 homeobox B (HNF-1β)-positive and… Expand
Is this relevant?
2013
2013
The clinicopathologic significance of p53 and BAF-250a (ARID1A) expression in clear cell carcinoma of the endometrium
TP53 mutation (and associated p53 protein overexpression) is probably a negative prognostic marker in endometrial cancers, but… Expand
  • figure 1
  • figure 2
  • figure 3
  • table 1
  • table 2
Is this relevant?
2012
2012
Diagnostic utility of hepatocyte nuclear factor 1-beta immunoreactivity in endometrial carcinomas: lack of specificity for endometrial clear cell carcinoma.
Hepatocyte nuclear factor 1-beta (HNF1β) has recently emerged as a relatively sensitive and specific marker for ovarian clear… Expand
  • figure 1
  • table 1
  • table 2
  • figure 2
Is this relevant?
2006
2006
Adjuvant whole abdominal irradiation in clinical stages I and II papillary serous or clear cell carcinoma of the endometrium: a phase II study of the Gynecologic Oncology Group.
OBJECTIVES To evaluate outcome in patients with clinical stage I/II papillary serous (PS) or clear cell (CC) endometrial… Expand
Is this relevant?
Highly Cited
2002
Highly Cited
2002
E-cadherin expression in endometrioid, papillary serous, and clear cell carcinoma of the endometrium.
OBJECTIVE To compare the frequency and pattern of E-cadherin expression in endometrioid, papillary serous, and clear cell… Expand
  • figure 1
  • table 1
  • table 3
  • table 2
Is this relevant?
Highly Cited
2000
Highly Cited
2000
The outcome of stage I-II clinically and surgically staged papillary serous and clear cell endometrial cancers when compared with endometrioid carcinoma.
PURPOSE The aim of this study was to compare survival and recurrence in clinical and surgical stage I-II papillary serous (PS… Expand
Is this relevant?
Highly Cited
1999
Highly Cited
1999
Epidemiologic and surgicopathologic findings of papillary serous and clear cell endometrial cancers when compared to endometrioid carcinoma.
PURPOSE The aim of this study was to identify similarities and differences in epidemiologic and surgicopathologic staging results… Expand
Is this relevant?
Highly Cited
1998
Highly Cited
1998
Clear cell carcinoma of the endometrium is characterized by a distinctive profile of p53, Ki-67, estrogen, and progesterone receptor expression.
This study was designed to analyze certain clinicopathological features and the profile of p53, Ki-67, estrogen (ER), and… Expand
Is this relevant?
1976
1976
Clear cell carcinoma of the endometrium: an analysis of 21 cases.
Twenty-one cases of clear cell carcinoma of the endometrium are analysed in an effort to characterize the histologic features and… Expand
Is this relevant?
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE